Reich Kristian sold MLTX
February 27, 2024 · Form 4 insider transaction
Reich Kristian sold 29,431 shares of MoonLake Immunotherapeutics at $55.00 per share, a transaction worth $1.62M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
29,431
Price
$55.00
Total value
$1.62M
InsiderReich Kristian
Role—
SecurityClass A ordinary shares, par value $0.0001 per share
Transaction codeS: Open-market sale
Transaction dateFebruary 27, 2024
Filing dateFebruary 29, 2024
Shares owned after70,071
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on October 16, 2023.